Our services
Request an appointment
Reserve your spot with our medical team in just minutes.
What This Test Detects
The Cancer Blood Test analyzes DNA fragments released into the bloodstream by cancer cells. These fragments form a unique genomic signature that allows early detection, often before imaging can identify changes. This test is also known as a “liquid biopsy”.
The test detects 59 cancers, including:
Pancreatic, liver, esophageal, stomach, lung, kidney, bladder, ovarian, cervical, uterine, breast, colon, bile duct, prostate and lymphoma.
This includes many cancers that have no regular screening options and are often diagnosed late.
Accuracy and Performance
88% sensitivity – If cancer is present, the test detects it about 88% of the time and follow up scans are ordered.
98% specificity – If the test is negative, there is a 98% chance that you truly do not have cancer.
A negative result indicates a high probability that no cancer DNA was detected. The test is significantly more powerful than full body MRI because it can detect microscopic DNA fragments that imaging cannot visualize.
What This Test Does Not Do
This test does not replace routine breast, colon or cervical screening. It complements standard medical care.
It is not recommended for individuals diagnosed with cancer within the last five years.
Eligibility
Recommended for adults aged 40 to 75, but is clinically indicated for ages 25 and up. The test has not been studied in pediatric populations, therefore children are not eligible.
Investment
Cost: $2,749 per test or $2,499 per test for corporate or groups of 10 or more people.
Eligible for many health spending accounts. This investment is tax-deductible.
Guaranteed Follow Up
If your test is positive, you will receive:
- A complimentary private CT scan or MRI within three weeks.
- Urgent referral to an oncology specialist if imaging confirms cancer.
- Direct follow up and guidance from Dr. Reid, while looping in your family doctor.
Your care does not end with the test result.